WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP2026-09-223,500$68.29
$239.02kSell
Fady Ibraham MalikEVP2026-09-223,500$7.80
$27.30kBuy
Robert I. BlumCEO;Pres2026-09-1597,926$69.33
$6.79MSell
Robert E. LandryDirector2026-09-151,000$72.13
$72.13kSell
Robert I. BlumCEO;Pres2026-09-147,500$73.44
$550.80kSell
Robert I. BlumCEO;Pres2026-09-147,500$10.60
$79.50kBuy
Robert E. LandryDirector2026-09-111,000$74.66
$74.66kSell
Fady Ibraham MalikEVP2026-09-083,500$75.46
$264.11kSell
Fady Ibraham MalikEVP2026-09-083,500$7.80
$27.30kBuy
B. Lynne ParshallDirector2026-09-015,000$71.48
$357.40kSell

1 of 19

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Schmertzler7.00%9,730,131$629.15MInsider
Eastern Capital Ltd2.07%2,883,845$186.47MInsider
Bvf Partners L P0.33%463,244$29.95MInsider
Robert I. Blum0.21%291,042$18.82MInsider
James A. Spudich0.13%180,600$11.68MInsider
Fady Ibraham Malik0.11%153,902$9.95MInsider
David Cragg0.11%153,233$9.91MInsider
Stephen M. Dow0.10%145,000$9.38MInsider
Jeffrey Hessekiel0.08%107,943$6.98MInsider
Mark A. Schlossberg0.07%103,408$6.69MInsider

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK0.12%10.96%Net SellingNet Selling
IBRX0.02%7.21%Net BuyingNet Selling
CAI0.05%81.85%Net BuyingNet Buying
PTGX0.12%22.54%Net SellingNet Buying
TGTX0.07%48.64%Net SellingNet Selling
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 0.12% institutional shareholders, 10.96% Cytokinetics insiders, and 88.93% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 7.00% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $629.15M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.